The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

The material is employed in a range of Edwards’ surgical and transcatheter valves, including versions of the Inspiris, Mitris ...

Edwards Lifesciences (NYSE: EW) today announced eight-year data highlighting positive long-term outcomes with its proprietary ...

Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up ...

Edwards Lifesciences (EW) announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary ...

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...

Over the last two decades, Edwards Lifesciences has demonstrated that it knows how to maintain leadership through innovation of tissue heart valves. Edwards remains the dominant force in surgical ...

London, Replacement heart ... new tissue," Dr. Tseng explained. "The scaffold gradually degrades and is replaced by our body's own tissues." The scaffold material used to make the valve is the ...

open as wide as it should, restricting blood flow through the heart - this means ... the atrium with a biological valve from a human donor or made from animal tissue from a pig or cow with a ...

Its product lineup includes tissue heart valves, valve repair systems, hemodynamic monitoring devices, angioscopy tools, oxygenators, and related pharmaceuticals. The company is slated to report ...